Related Experiment Video
Updated: Jun 13, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
FoxO proteins and cardiac pathology
Albert Wong1, Elizabeth A Woodcock
1Molecular Cardiology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Abstract:
The FoxO family of transcription factors mediate a wide range of cellular responses from cell death to cell survival, growth inhibition and glucose utilization. This complex array of responses is regulated by an equally complex regulatory system, involving phosphorylation, ubiquitinization and acetylation, in addition to interactions with other transcription factors and transcriptional modifiers. In heart, FoxO proteins have been shown to be involved in development in limiting hypertrophic growth responses and in cardioprotection provided by silent information regulator 1 (Sirt1). However, the range of responses mediated by FoxO proteins and the clear evidence for involvement of FoxO regulators in cardiac pathology, suggest that further pathological actions of FoxO family members remain to be elucidated.
Insights
Forkhead box O (FoxO) transcription factors regulate diverse cellular functions. Their role in heart pathology, beyond development and cardioprotection, requires further investigation to understand their full impact.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cardiovascular Research
Background:
- Forkhead box O (FoxO) transcription factors orchestrate critical cellular processes including apoptosis, survival, growth inhibition, and glucose metabolism.
- The regulation of FoxO proteins is intricate, involving post-translational modifications like phosphorylation, ubiquitination, and acetylation, alongside interactions with other regulatory proteins.
- In the heart, FoxO proteins are implicated in limiting hypertrophy during development and in mediating cardioprotection via interactions with silent information regulator 1 (Sirt1).
Purpose of the Study:
- To explore the broader spectrum of cellular responses regulated by FoxO proteins.
- To investigate the potential, yet unelucidated, pathological roles of FoxO family members in cardiac conditions.
Main Methods:
- Review and synthesis of existing literature on FoxO transcription factors and their roles in cellular and cardiac physiology.
- Analysis of regulatory mechanisms governing FoxO activity, including post-translational modifications and protein-protein interactions.
- Examination of evidence linking FoxO regulators to cardiac pathology.
Main Results:
- FoxO proteins control a wide array of cellular functions, demonstrating significant versatility in biological responses.
- Complex regulatory networks involving phosphorylation, ubiquitination, acetylation, and interactions with other factors modulate FoxO activity.
- Established roles in cardiac development and Sirt1-mediated cardioprotection highlight FoxO's importance in the heart.
Conclusions:
- The multifaceted roles of FoxO proteins extend beyond their known functions in the heart.
- Given their involvement in various cellular processes and known cardiac functions, further research is warranted to fully elucidate the pathological implications of FoxO family members in cardiovascular disease.
Related Concept Videos
Pathophysiology of Cardiac Performance
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

